Quick Answer
Veradermics, Inc reported Diluted EPS of $111.91 per share (loss) for fiscal year 2025.
Veradermics, Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$111.91 | -202.1% |
| 2024 | -$37.05 | — |
- Veradermics, Inc showed a decrease of -202.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, Veradermics, Inc’s diluted eps has declined by 202.1% (from $37.05 per share (loss) to $111.91 per share (loss)).
- The most recent figure is from Veradermics, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: